SE.CN Sweet Earth Holdings Corporation CNQ at C$0.51: Oversold bounce potential
SE.CN stock trades at C$0.51 on 19 Jan 2026 during market hours, and we see a short-term oversold bounce setup. Volume is light at 2,100.00 shares, but the stock is above its 200-day average of C$0.37 and below the 50-day average of C$0.56, a classic recovery window. We outline fundamentals, technicals, a Meyka grade, and a measured price forecast to frame a trade idea in Canada (CNQ) and show why traders watch for a bounce.
SE.CN stock: Quick company snapshot and recent price action
Sweet Earth Holdings Corporation (SE.CN) is listed on the CNQ exchange in Canada and develops CBD and hemp skincare products and related consumer items. The share price is C$0.51, year high C$0.74 and year low C$0.10, with market cap roughly C$6,586,663.00 and shares outstanding 12,915,025.00. Recent trading is thin versus larger peers, with average volume 2,994.00 and today’s volume 2,100.00, which raises execution risk for larger orders. For background reading see the company profile on Bloomberg and a recent summary at MarketBeat.
SE.CN stock: Why we see an oversold bounce setup
Price sits below the 50-day average (C$0.56) and above the 200-day average (C$0.37), creating a mean-reversion candidate for short-term traders. The stock’s 3-month change is down 19.05% while the 6-month change is up 96.15%, signaling volatile swings that can produce rapid bounces. We note the low on-day range (C$0.51 to C$0.51) and muted volume, which means a small trade can move the price and produce a quick recovery if buying interest returns.
SE.CN stock: Fundamentals, valuation and sector context
Sweet Earth reports EPS 0.21 and a reported P/E of 2.43, which looks inexpensive versus the Healthcare sector average P/E of 14.43. Trailing operating cash flow per share is negative at -0.09 and cash per share is 0.22, reflecting tight liquidity. The balance sheet shows enterprise value C$6,466,963.00 and a debt-to-assets metric near 0.96, so leverage is a material consideration. While the P/E looks attractive, we flag negative free cash flow and a stretched payables profile when comparing SE.CN to broader Healthcare peers.
SE.CN stock: Technicals, trading signal and Meyka grade
Technically, the short-term pattern shows a price gap versus the 50-day average and a low relative volume reading, consistent with oversold-bounce trade setups we monitor. Momentum indicators are sparse on this ticker, but mean-reversion from the 200-day average is a plausible path if buyers return. Meyka AI rates SE.CN with a score out of 100: 58.67 | Grade: C+ | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and are for informational use only.
SE.CN stock: Price targets, Meyka AI forecast and trade plan
Meyka AI’s forecast model projects a one-year target of C$0.82, implying an upside of 60.78% from the current C$0.51. A conservative downside case to C$0.40 implies -21.57%, while a stressed downside to C$0.35 would be -31.37%. Forecasts are model-based projections and not guarantees. For traders following an oversold bounce strategy we suggest a tight risk bracket, watching for a volume pickup above 3,000.00 shares and a close above C$0.56 to confirm the bounce. We link company details at our internal Meyka page for live tracking: Meyka SE.CN page.
SE.CN stock: Risks, catalysts and sector drivers
Key risks include low liquidity, negative cash flow per share (operating -0.09), and concentration in CBD skincare where regulation and competition matter. Catalysts that could trigger a sustained bounce include a liquidity increase, a positive corporate update, or stronger sector flows into Healthcare small-caps. We also monitor macro sentiment and Canadian Healthcare sector performance, since SE.CN will track risk-on moves in small-cap Healthcare names.
Final Thoughts
SE.CN stock at C$0.51 presents a classic oversold-bounce setup for short-term traders, driven by a price below the 50-day average yet above the 200-day average and a low trading volume that can magnify moves. Fundamentals are mixed: EPS 0.21 and an attractive P/E of 2.43 contrast with negative operating cash flow per share (-0.09) and tight liquidity. Meyka AI’s model projects C$0.82 as a one-year target (+60.78% upside) while conservative downside scenarios sit near C$0.40 (-21.57%). We rate SE.CN as a speculative HOLD under our grade, suitable for risk-tolerant traders who manage position size, enforce stop-losses, and watch for volume above 3,000.00 to confirm momentum. These price forecasts are model-based projections and not guarantees; our coverage is provided by Meyka AI as an AI-powered market analysis platform to help frame the trade idea while you do your own research.
FAQs
Is SE.CN stock a buy right now?
SE.CN stock is a speculative HOLD under Meyka’s grade; the setup looks like a short-term oversold bounce. Traders may buy small positions with tight stops and volume confirmation over 3,000.00 shares. This is not financial advice.
What are SE.CN stock key financial metrics to watch?
Watch EPS 0.21, P/E 2.43, operating cash flow per share -0.09, and cash per share 0.22. Also monitor liquidity and daily volume versus the 50-day average for SE.CN stock risk management.
What price target does Meyka give for SE.CN stock?
Meyka AI’s forecast model projects a one-year target of C$0.82, implying +60.78% upside from C$0.51. Forecasts are model-based projections and not guarantees.
What are the main risks for SE.CN stock investors?
Main risks for SE.CN stock include low liquidity, negative free cash flow, high debt-to-assets, and industry regulatory shifts in CBD products. Position sizing and stop-loss discipline are essential.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
